𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Failure to confirm coxsackievirus infection in primary Sjögren's syndrome

✍ Scribed by Jacques-Eric Gottenberg; Coralie Pallier; Marc Ittah; Frédéric Lavie; Corinne Miceli-Richard; Jérémie Sellam; Patrice Nordmann; Nicolas Cagnard; Jean Sibilia; Xavier Mariette

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
63 KB
Volume
54
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence for coxsackievirus infection in
Evidence for coxsackievirus infection in primary Sjögren's syndrome
✍ Antigoni Triantafyllopoulou; Nikos Tapinos; Haralampos M. Moutsopoulos 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

## Abstract ## Objective Primary Sjögren's syndrome (SS) is an autoimmune disease characterized by activation of minor salivary gland (MSG) epithelial cells and B and T lymphocytic infiltrates. These findings have long encouraged the hypothesis that a persistent viral infection of the MSG epitheli

Shrinking lung in primary Sjögren's synd
Shrinking lung in primary Sjögren's syndrome
✍ Antonio Tavoni; Claudio Vitali; Giovanna Cirigliano; Sabrina Frigelli; Giulia St 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 1 views
Inefficacy of infliximab in primary Sjög
Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)
✍ Xavier Mariette; Philippe Ravaud; Serge Steinfeld; Gabriel Baron; Joelle Goetz; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Objective: There is no effective treatment for patients with primary sjögren's syndrome (ss). since tumor necrosis factor alpha (tnf alpha) could be a key element in the pathogenesis of primary ss, we conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the eff